190 related articles for article (PubMed ID: 3266005)
21. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
Marchant CD; Band E; Froeschle JE; McVerry PH
Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
Eskola J; Peltola H; Takala AK; Käyhty H; Hakulinen M; Karanko V; Kela E; Rekola P; Rönnberg PR; Samuelson JS
N Engl J Med; 1987 Sep; 317(12):717-22. PubMed ID: 3306379
[TBL] [Abstract][Full Text] [Related]
23. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
[TBL] [Abstract][Full Text] [Related]
24. Prospective comparison of the immune response of infants to three Haemophilus influenzae type b vaccines.
Turner RB; Cimino CO; Sullivan BJ
Pediatr Infect Dis J; 1991 Feb; 10(2):108-12. PubMed ID: 2062600
[TBL] [Abstract][Full Text] [Related]
25. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population.
Santosham M; Hill J; Wolff M; Reid R; Lukacs L; Ahonkhai V
Pediatr Infect Dis J; 1991 Feb; 10(2):113-7. PubMed ID: 2062601
[TBL] [Abstract][Full Text] [Related]
26. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group.
Ward J; Brenneman G; Letson GW; Heyward WL
N Engl J Med; 1990 Nov; 323(20):1393-401. PubMed ID: 2233906
[TBL] [Abstract][Full Text] [Related]
27. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.
Santosham M; Englund JA; McInnes P; Croll J; Thompson CM; Croll L; Glezen WP; Siber GR
Pediatr Infect Dis J; 2001 Oct; 20(10):931-40. PubMed ID: 11642626
[TBL] [Abstract][Full Text] [Related]
28. Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine.
Reid R; Santosham M; Croll J; Thompson C; Newcomer W; Siber GR
Pediatr Infect Dis J; 1993 Oct; 12(10):812-5. PubMed ID: 8284116
[TBL] [Abstract][Full Text] [Related]
29. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP).
MMWR Recomm Rep; 1991 Jan; 40(RR-1):1-7. PubMed ID: 1899280
[TBL] [Abstract][Full Text] [Related]
30. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER
Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
[TBL] [Abstract][Full Text] [Related]
31. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
[TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
34. Antibody responses to four Haemophilus influenzae type b conjugate vaccines.
Käyhty H; Eskola J; Peltola H; Rönnberg PR; Kela E; Karanko V; Saarinen L
Am J Dis Child; 1991 Feb; 145(2):223-7. PubMed ID: 1994693
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of Haemophilus influenzae type B vaccines in children with hepatoportoenterostomies.
Rosenthal P; Wong V; Ross LA; Kim KS
J Pediatr Gastroenterol Nutr; 1990 Aug; 11(2):201-4. PubMed ID: 2395059
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
37. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis.
Wenger JD; Ward JI; Broome CV
Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698
[No Abstract] [Full Text] [Related]
38. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
[TBL] [Abstract][Full Text] [Related]
39. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
Adderson EE; Chisholm N; Halperin SA
Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
[TBL] [Abstract][Full Text] [Related]
40. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
